Muraro et al., 1989 - Google Patents
A monoclonal antibody (D612) with selective reactivity for malignant and normal gastro‐intestinal epitheliumMuraro et al., 1989
- Document ID
- 3676611836533930199
- Author
- Muraro R
- Nuti M
- Natali P
- Bigotti A
- Simpson J
- Primus F
- Colcher D
- Greiner J
- Schlom J
- Publication year
- Publication venue
- International journal of cancer
External Links
Snippet
We describe the generation and characterization of a monoclonal antibody (MAb), designated D612, with selective reactivity for malignant and normal gastro‐intestinal epithelium. MAb D612, a murine lgG2a, was generated using a membrane‐enriched fraction …
- 108010045030 monoclonal antibodies 0 title abstract description 103
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3053—Skin, nerves, brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody or an immunoglobulin, or a fragment thereof, e.g. a camelised human single domain antibody, or the Fc fragment of an antibody
- A61K51/1003—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody or an immunoglobulin, or a fragment thereof, e.g. a camelised human single domain antibody, or the Fc fragment of an antibody not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5183756A (en) | Monoclonal antibody (D612) having selective reactivity for gastrointestinal caricinomas and method for employing the same | |
| Mujoo et al. | Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth | |
| DE3856108T2 (en) | SECOND GENERATION MONOCLONAL ANTIBODIES WITH BINDING SPECIFICITY FOR TAG-72 AND HUMAN CARCINOMAS AND METHODS FOR THEIR USE | |
| Bosslet et al. | Immunohistochemical localization and molecular characteristics of three monoclonal antibody‐defined epitopes detectable on carcinoembryonic antigen (CEA) | |
| Hilkens et al. | Monoclonal antibodies against human milk‐fat globule membranes detecting differentiation antigens of the mammary gland and its tumors | |
| US5160723A (en) | Method of imaging colorectal carcinoma lesion and composition for use therein | |
| EP0118365B1 (en) | Monoclonal antibodies to human breast carcinoma cells and their use in diagnosis and therapy | |
| US5320956A (en) | Monoclonal antibody useful for the diagnosis of cancer | |
| Stein et al. | Murine monoclonal antibodies raised against human non-small cell carcinoma of the lung: specificity and tumor targeting | |
| Ohuchi et al. | Complementation of anti‐CEA and anti‐TAG‐72 monoclonal antibodies in reactivity to human gastric adenocarcinomas | |
| Kuroki et al. | Serologic mapping and biochemical characterization of the carcinoembryonic antigen epitopes using fourteen distinct monoclonal antibodies | |
| Marx | Monoclonal Antibodies in Cancer: Clinical trials of monoclonal antibodies in cancer therapy are beginning, but the best bet for their use may be in cancer detection | |
| DE3854581T2 (en) | ANTIGAS SF-25 OF THE COLONAL ADENOCARCINOMA AND ANTIBODIES THAT RECOGNIZE THIS ANTIQUE. | |
| MAsuKo et al. | Human bladder cancer cell-surface antigens recognized by murine monoclonal antibodies raised against T24 bladder cancer cells | |
| Muraro et al. | A monoclonal antibody (D612) with selective reactivity for malignant and normal gastro‐intestinal epithelium | |
| US7741444B2 (en) | Neoplasm specific antibodies and uses thereof | |
| US4731238A (en) | Novel monoclonal hybridoma and corresponding antibody | |
| JP3284133B2 (en) | Monoclonal antibody confirms glycoprotein of human milk fat globule membrane mucin antigen | |
| US5431897A (en) | Method of imaging colorectal carcinoma lesion and composition for use therein | |
| AU670247B2 (en) | Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof | |
| Camera et al. | Preclinical evaluation of 111In-labeled B3 monoclonal antibody: biodistribution and imaging studies in nude mice bearing human epidermoid carcinoma xenografts | |
| Sikora | Monoclonal antibodies in oncology. | |
| AU2004289821B2 (en) | Adenocarcinoma specific antibody SAM-6, and uses thereof | |
| Martin et al. | Characterization of the antigen identified by Po66: A monoclonal antibody raised against a lung squamous cell carcinoma | |
| Carpenet et al. | Radiolabelled polymeric IgA: from biodistribution to a new molecular imaging tool in colorectal cancer lung metastases |